TIME‐TO‐RESPONSE FOR PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B CELL NON‐HODGKIN LYMPHOMA TREATED WITH POLATUZUMAB‐BASED THERAPY.
| Autor: | Hughes, M. E., Nasta, S. D., Gerson, J. N., Svoboda, J., Chong, E. A., Schuster, S. J., Barta, S. K., Robinson, K. W., Landsburg, D. J. |
|---|---|
| Zdroj: | Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text